Home
About
Overview
Sharing Data
ORCID
Help
History (42)
Is there a role for clozapine in the treatment of children and adolescents?
Low Disclosure of PrEP Nonadherence and HIV-Risk Behaviors Associated With Poor HIV PrEP Adherence in the HPTN 067/ADAPT Study.
A peptide flavoprotein mimic: flavin recognition and redox potential modulation in water by a designed beta hairpin.
Smoking cessation counseling by family physicians.
KRAS mutation in colon cancer: a marker of resistance to EGFR-I therapy.
See All 42 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
KRAS mutation in colon cancer: a marker of resistance to EGFR-I therapy.
Siddiqui AD, Piperdi B. KRAS mutation in colon cancer: a marker of resistance to EGFR-I therapy. Ann Surg Oncol. 2010 Apr; 17(4):1168-76.
View in:
PubMed
subject areas
Antineoplastic Agents
Biomarkers, Tumor
Clinical Trials as Topic
Colonic Neoplasms
Drug Resistance, Neoplasm
ErbB Receptors
Humans
Mutation
Proto-Oncogene Proteins
Proto-Oncogene Proteins p21(ras)
ras Proteins